These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 25557875)

  • 1. Factors circulating in the blood of type 2 diabetes mellitus patients affect osteoblast maturation - description of a novel in vitro model.
    Ehnert S; Freude T; Ihle C; Mayer L; Braun B; Graeser J; Flesch I; Stöckle U; Nussler AK; Pscherer S
    Exp Cell Res; 2015 Mar; 332(2):247-58. PubMed ID: 25557875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperinsulinemia reduces osteoblast activity in vitro via upregulation of TGF-β.
    Freude T; Braun KF; Haug A; Pscherer S; Stöckle U; Nussler AK; Ehnert S
    J Mol Med (Berl); 2012 Nov; 90(11):1257-66. PubMed ID: 22926010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TNF-α is upregulated in T2DM patients with fracture and promotes the apoptosis of osteoblast cells in vitro in the presence of high glucose.
    Sun M; Yang J; Wang J; Hao T; Jiang D; Bao G; Liu G
    Cytokine; 2016 Apr; 80():35-42. PubMed ID: 26945994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct proliferative and differentiated stages of murine MC3T3-E1 cells in culture: an in vitro model of osteoblast development.
    Quarles LD; Yohay DA; Lever LW; Caton R; Wenstrup RJ
    J Bone Miner Res; 1992 Jun; 7(6):683-92. PubMed ID: 1414487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biphasic effects of transforming growth factor β on bone morphogenetic protein-induced osteoblast differentiation.
    de Gorter DJ; van Dinther M; Korchynskyi O; ten Dijke P
    J Bone Miner Res; 2011 Jun; 26(6):1178-87. PubMed ID: 21611961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigation for TGF-β1 expression in type 2 diabetes and protective effects of TGF-β1 on osteoblasts under high glucose environment.
    Wang WD; Cheng BZ; Kang WB; Zheng RW; Cai YL; Wang XJ
    Eur Rev Med Pharmacol Sci; 2018 Oct; 22(19):6500-6506. PubMed ID: 30338820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Collagen, type V, alpha1 (COL5A1) is regulated by TGF-beta in osteoblasts.
    Kahai S; Vary CP; Gao Y; Seth A
    Matrix Biol; 2004 Nov; 23(7):445-55. PubMed ID: 15579311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TGF beta alters growth and differentiation related gene expression in proliferating osteoblasts in vitro, preventing development of the mature bone phenotype.
    Breen EC; Ignotz RA; McCabe L; Stein JL; Stein GS; Lian JB
    J Cell Physiol; 1994 Aug; 160(2):323-35. PubMed ID: 8040190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A recombinant human TGF-beta1 fusion protein with collagen-binding domain promotes migration, growth, and differentiation of bone marrow mesenchymal cells.
    Andrades JA; Han B; Becerra J; Sorgente N; Hall FL; Nimni ME
    Exp Cell Res; 1999 Aug; 250(2):485-98. PubMed ID: 10413602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Porcine fetal enamel matrix derivative stimulates proliferation but not differentiation of pre-osteoblastic 2T9 cells, inhibits proliferation and stimulates differentiation of osteoblast-like MG63 cells, and increases proliferation and differentiation of normal human osteoblast NHOst cells.
    Schwartz Z; Carnes DL; Pulliam R; Lohmann CH; Sylvia VL; Liu Y; Dean DD; Cochran DL; Boyan BD
    J Periodontol; 2000 Aug; 71(8):1287-96. PubMed ID: 10972644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dexamethasone, BMP-2, and 1,25-dihydroxyvitamin D enhance a more differentiated osteoblast phenotype: validation of an in vitro model for human bone marrow-derived primary osteoblasts.
    Jørgensen NR; Henriksen Z; Sørensen OH; Civitelli R
    Steroids; 2004 Apr; 69(4):219-26. PubMed ID: 15183687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Osteoclast inhibitory lectin (OCIL) inhibits osteoblast differentiation and function in vitro.
    Nakamura A; Ly C; Cipetić M; Sims NA; Vieusseux J; Kartsogiannis V; Bouralexis S; Saleh H; Zhou H; Price JT; Martin TJ; Ng KW; Gillespie MT; Quinn JM
    Bone; 2007 Feb; 40(2):305-15. PubMed ID: 17049328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dkk1-induced inhibition of Wnt signaling in osteoblast differentiation is an underlying mechanism of bone loss in multiple myeloma.
    Qiang YW; Barlogie B; Rudikoff S; Shaughnessy JD
    Bone; 2008 Apr; 42(4):669-80. PubMed ID: 18294945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The developmental stages of osteoblast growth and differentiation exhibit selective responses of genes to growth factors (TGF beta 1) and hormones (vitamin D and glucocorticoids).
    Lian JB; Stein GS
    J Oral Implantol; 1993; 19(2):95-105; discussion 136-7. PubMed ID: 8246305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TGF-β
    Ehnert S; Sreekumar V; Aspera-Werz RH; Sajadian SO; Wintermeyer E; Sandmann GH; Bahrs C; Hengstler JG; Godoy P; Nussler AK
    J Mol Med (Berl); 2017 Jun; 95(6):653-663. PubMed ID: 28271209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucocorticoids promote development of the osteoblast phenotype by selectively modulating expression of cell growth and differentiation associated genes.
    Shalhoub V; Conlon D; Tassinari M; Quinn C; Partridge N; Stein GS; Lian JB
    J Cell Biochem; 1992 Dec; 50(4):425-40. PubMed ID: 1469073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transforming growth factor-beta 1 (TGF-beta1) prevents the age-dependent decrease in bone formation in human osteoblast/implant cultures.
    Zhang H; Aronow MS; Gronowicz GA
    J Biomed Mater Res A; 2005 Oct; 75(1):98-105. PubMed ID: 16044414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of type I collagen on the development and maintenance of the osteoblast phenotype in primary and passaged rat calvarial osteoblasts: modification of expression of genes supporting cell growth, adhesion, and extracellular matrix mineralization.
    Lynch MP; Stein JL; Stein GS; Lian JB
    Exp Cell Res; 1995 Jan; 216(1):35-45. PubMed ID: 7813631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delayed bone regeneration and low bone mass in a rat model of insulin-resistant type 2 diabetes mellitus is due to impaired osteoblast function.
    Hamann C; Goettsch C; Mettelsiefen J; Henkenjohann V; Rauner M; Hempel U; Bernhardt R; Fratzl-Zelman N; Roschger P; Rammelt S; Günther KP; Hofbauer LC
    Am J Physiol Endocrinol Metab; 2011 Dec; 301(6):E1220-8. PubMed ID: 21900121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of potential modifiers of Runx2/Cbfa1 activity in C2C12 cells in response to bone morphogenetic protein-7.
    Gu K; Zhang L; Jin T; Rutherford RB
    Cells Tissues Organs; 2004; 176(1-3):28-40. PubMed ID: 14745233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.